Article: A new patient with a terminal de novo 2p25.3 deletion of 1.9 Mb associated with early-onset of obesity, intellectual disabilities and hyperkinetic disorder

Terminal and interstitial deletions of 2p25.3 (size < Mb), detected by array-CGH analysis, have been reported in about 18 patients sharing common clinical features represented by early-onset obesity/ overweightness associated with intellectual disabilities (ID) and behavioural troubles. This observations led to hypothesize that 2p subtelomeric deletion should be associated with syndromic obesity and MYT1L became the main candidate gene for ID and obesity since it is deleted or disrupted in all hitherto published cases. Here we described a 2p25.3 de novo terminal deletion of 1.9 Mb, of paternal origin, detected by array-CGH analysis in a girl of 4.4 years with a distinctive phenotype consisting of early-onset of obesity associated with moderate ID, and hyperkinetic disorder. The deletion disrupted MYT1L and encompassed five other OMIM genes, ACP1, TMEM18, SNTG2, TPO, and PXDN. Here, we discuss the combined functional effects of additional haploinsufficient genes, that may concur with heterozygous deletion of MYT1L, in the aetiology for syndromic obesity associated with 2p25.5 subtelomeric deletion.

Citing Articles

DNA Methylation of Is Associated with Early-Life Adversity in Adult Mental Disorders.

Edelmann S, Balaji J, Pasche S, Wiegand A, Nieratschker V Biomolecules. 2024; 14(8).

PMID: 39199364 PMC: 11353138. DOI: 10.3390/biom14080976.

Identifying Genetic Etiology in Patients with Intellectual Disability: An Experience in Public Health Services in Northeastern Brazil.

de Carvalho A, Alves E, Pitanga P, Ribeiro E, Doriqui M, Pereira Toralles M J Pediatr Genet. 2024; 13(2):90-98.

PMID: 38721574 PMC: 11076089. DOI: 10.1055/s-0042-1757888.

Myt1l haploinsufficiency leads to obesity and multifaceted behavioral alterations in mice.

Wohr M, Fong W, Janas J, Mall M, Thome C, Vangipuram M Mol Autism. 2022; 13(1):19.

PMID: 35538503 PMC: 9087967. DOI: 10.1186/s13229-022-00497-3.

A genome-wide methylation study reveals X chromosome and childhood trauma methylation alterations associated with borderline personality disorder.

Arranz M, Gallego-Fabrega C, Martin-Blanco A, Soler J, Elices M, Dominguez-Clave E Transl Psychiatry. 2021; 11(1):5.

PMID: 33414392 PMC: 7791113. DOI: 10.1038/s41398-020-01139-z.

MYT1L: A systematic review of genetic variation encompassing schizophrenia and autism.

Mansfield P, Constantino J, Baldridge D Am J Med Genet B Neuropsychiatr Genet. 2020; 183(4):227-233.

PMID: 32267091 PMC: 7605444. DOI: 10.1002/ajmg.b.32781.

References

1.

Yoo A, Sun A, Li L, Shcheglovitov A, Portmann T, Li Y . MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011; 476(7359):228-31. PMC: 3348862. DOI: 10.1038/nature10323. View

2.

Doco-Fenzy M, Leroy C, Schneider A, Petit F, Delrue M, Andrieux J . Early-onset obesity and paternal 2pter deletion encompassing the ACP1, TMEM18, and MYT1L genes. Eur J Hum Genet. 2013; 22(4):471-9. PMC: 3953915. DOI: 10.1038/ejhg.2013.189. View

3.

Lopez-Uriarte A, Quintero-Rivera F, de la Fuente Cortez B, Puente V, Campos M, Martinez de Villarreal L . Ring 2 chromosome associated with failure to thrive, microcephaly and dysmorphic facial features. Gene. 2013; 529(1):65-8. DOI: 10.1016/j.gene.2013.06.056. View

4.

Bonaglia M, Giorda R, Massagli A, Galluzzi R, Ciccone R, Zuffardi O . A familial inverted duplication/deletion of 2p25.1-25.3 provides new clues on the genesis of inverted duplications. Eur J Hum Genet. 2008; 17(2):179-86. PMC: 2986066. DOI: 10.1038/ejhg.2008.160. View

5.

Rio M, Royer G, Gobin S, de Blois M, Ozilou C, Bernheim A . Monozygotic twins discordant for submicroscopic chromosomal anomalies in 2p25.3 region detected by array CGH. Clin Genet. 2012; 84(1):31-6. DOI: 10.1111/cge.12036. View

6.

Stevens S, van Ravenswaaij-Arts C, Janssen J, Klein Wassink-Ruiter J, van Essen A, Dijkhuizen T . MYT1L is a candidate gene for intellectual disability in patients with 2p25.3 (2pter) deletions. Am J Med Genet A. 2011; 155A(11):2739-45. DOI: 10.1002/ajmg.a.34274. View

7.

Chen C, Lin C, Chang T, Chern S, Wu P, Chen Y . Prenatal diagnosis of ring chromosome 2 with lissencephaly and 2p25.3 and 2q37.3 microdeletions detected using array comparative genomic hybridization. Gene. 2013; 519(1):164-8. DOI: 10.1016/j.gene.2013.01.055. View

8.

Paggi A, Borgiani P, Gloria-Bottini F, Russo S, Saponara I, Banci M . Further studies on acid phosphatase in obese subjects. Dis Markers. 1991; 9(1):1-7. View

9.

Vierbuchen T, Ostermeier A, Pang Z, Kokubu Y, Sudhof T, Wernig M . Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010; 463(7284):1035-41. PMC: 2829121. DOI: 10.1038/nature08797. View

10.

Dee S, Clark A, Willatt L, Yates J . A case of ring chromosome 2 with growth retardation, mild dysmorphism, and microdeletion of 2p detected using FISH. J Med Genet. 2001; 38(9):E32. PMC: 1734942. DOI: 10.1136/jmg.38.9.e32. View

11.

De Lorenzo A, Di Renzo L, Puja A, Saccucci P, Gloria-Bottini F, Bottini E . A study of acid phosphatase locus 1 in women with high fat content and normal body mass index. Metabolism. 2009; 58(3):351-4. DOI: 10.1016/j.metabol.2008.10.007. View

A New Patient with a Terminal De Novo 2p25.3 Deletion of 1.9 Mb Associated with Early-onset of Obesity, Intellectual Disabilities and Hyperkinetic Disorder